Olfactory dysfunction in patients with Huntington disease
Objective: To investigate olfactory dysfunction (OD) in individuals with Huntington disease (HD) and its relation to disease severity. Background: HD is a hereditary neurodegenerative disease…Factors that negatively impact the sexual function of women living with Parkinson’s disease
Objective: To investigate the impact of motor and non-motor alterations and couple adjustment on sexual function in women living with PD in Brazil. Background: Among…The clinical challenge of an unilateral abnormal uptake in datscan
Objective: Characterize patients with unilateral abnormal uptake in DaTscan. Background: Presynaptic dopamine transporter (DaT) single-photon emission computed tomography (SPECT) imaging is the most used imaging…A PROSPECTIVE COHORT STUDY OF COGNITIVE IMPAIRMENT AND CORTISOL LEVELS IN PARKINSON’S DISEASE
Objective: To assess cognitive impairment and cortisol levels in PD in a 14-month cohort study. Background: Cognitive impairment is one of the most common non-motor…Investigating genetic risk factors for Lewy body dementia
Objective: We aim to investigate the genetic mutations related to the development of dementia in Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB)…Alteration of the fecal microbiota in Turkish patients with idiopathic Parkinson’s disease
Objective: To determine whether the gut microbiota is altered in Turkish patients with Parkinson Disease (PD) and the potential effect of gut microbiota on pre-motor…Hemichorea-hemiballismus syndrome without damage to the subthalamic nucleus?
Objective: Discuss a case of Non-ketotic hyperglycemia hemiballismus hemichorea that preserves the subthalamic nucleus (STN). Background: Non-ketotic hyperglycemia hemiballismus hemichorea is a pathology characterized by…Successful treatment of Stiff Person Syndrome with botulinum toxin
Objective: Describe a case of Stiff Person Syndrome (SPS) treated with botulinum toxin injection and alert to the utility of botulinum toxin in this disorder.…Effect of KW-6356, a novel adenosine A2A receptor antagonist/inverse agonist, on motor and non-motor symptoms in Parkinson’s disease patients as an adjunct to levodopa therapy: Results of Phase 2b study
Objective: To evaluate the efficacy and safety of KW-6356 in Parkinson’s disease (PD) patients with levodopa therapy, irrespective of the presence of wearing-off (WO). Background:…Use of apomorphine infusion pump in the elderly population : a 5 years follw up study on efficacy, safety and tolerability in a cohort bases study
Objective: Evaluate the efficacy, tolerability and safety of subcutaneous apomorphine infusion in elderly patients with advanced Parkinson's disease in a five years follow up cohort. Background: Continuous infusion by subcutaneous apomorphine pump has…
- « Previous Page
- 1
- …
- 107
- 108
- 109
- 110
- 111
- …
- 153
- Next Page »